Sustained Exogenous Expression of Therapeutic Levels of IFN-γ Ameliorates Atopic Dermatitis in NC/Nga Mice via Th1 Polarization
Open Access
- 1 March 2010
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 184 (5) , 2729-2735
Abstract
The short in vivo half-life of IFN-γ can prevent the cytokine from inducing immunological changes that are favorable for the treatment of Th2-dominant diseases, such as atopic dermatitis. To examine whether a sustained supply of IFN-γ is effective in regulating the balance of Th lymphocyte subpopulations, plasmid vector encoding mouse IFN-γ, pCpG-Muγ, or pCMV-Muγ was injected into the tail vein of NC/Nga mice, a model for human atopic dermatitis. A single hydrodynamic injection of a CpG motif reduced pCpG-Muγ at a dose of 0.14 μg/mouse resulted in a sustained concentration of IFN-γ in the serum, and the concentration was maintained at >300 pg/ml over 80 d. The pCpG-Muγ–mediated IFN-γ gene transfer was associated with an increase in the serum concentration of IL-12, reduced production of IgE, and inhibition of mRNA expression of IL-4, -5, -10, -13, and -17 and thymus and activation-regulated chemokine in the spleen. These immunological changes were not clearly observed in mice receiving two injections of 20 μg pCMV-Muγ, a CpG-replete plasmid DNA, because of the transient nature of the expression from the vector. The mice receiving pCpG-Muγ showed a significant reduction in the severity of skin lesions and in the intensity of their scratching behavior. Furthermore, high transepidermal water loss, epidermal thickening, and infiltration of lymphocytes and eosinophils, all of which were obvious in the untreated mice, were significantly inhibited. These results indicate that an extraordinary sustained IFN-γ expression induces favorable immunological changes, leading to a Th1-dominant state in the atopic dermatitis model.Keywords
This publication has 42 references indexed in Scilit:
- Significance of the cytokine interferon gamma in clinical dermatologyClinical and Experimental Dermatology, 2004
- The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?Immunology, 2004
- Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gammaJournal of the American Academy of Dermatology, 2000
- Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis–like lesionsJournal of Clinical Investigation, 1999
- Interferon-γ Therapy Reduces Blood Leukocyte Levels in Patients with Atopic Dermatitis: Correlation with Clinical ImprovementClinical Immunology, 1999
- Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitisJournal of Clinical Investigation, 1999
- Blood eosinophils and serum IgE as predictors for prognosis of interferongamma therapy in atopic dermatitisAllergy, 1998
- A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitisImmunology Today, 1998
- Long-term Effectiveness and Safety of Recombinant Human Interferon Gamma Therapy for Atopic Dermatitis Despite Unchanged Serum IgE LevelsArchives of Dermatology, 1998
- Atopic dermatitis—immunological abnormality and its backgroundJournal of Dermatological Science, 1994